Ebola Vaccine: Is it over?
Volunteers4Humanity - Providing free medical and dental care worldwide.
RSS Follow Become a Fan

Delivered by FeedBurner


Recent Posts

Opioids Toxification and Detoxification
Severe Malaria in a Resource-Constrained Setting
One-third of US Doctors are Female
Myasthenia gravis
Crohn's Disease

Categories

415-Bed Lira Hospital serves 4 million people
DC Circle of Friends
Volunteer Update

Archives

August 2017
July 2017
June 2017
May 2017
April 2017
March 2017
February 2017
January 2017
December 2016
November 2016
October 2016
September 2016
August 2016
July 2016
June 2016
May 2016
April 2016
March 2016
February 2016
January 2016
December 2015
November 2015
October 2015
September 2015
August 2015
July 2015
June 2015
May 2015
April 2015
March 2015
February 2015
January 2015
December 2014
November 2014
October 2014
September 2014
August 2014
July 2014
June 2014
May 2014
April 2014
February 2014
January 2014
December 2013
November 2013
October 2013
September 2013
August 2013

powered by

Blog for Volunteers4Humanity

Ebola Vaccine: Is it over?

The internet has exploded with news of the preliminary results from the Guinea Ebola trial vaccination! Published in the latest edition of Lancet, researchers have announced that a new vaccine has been 100 percent effective in those that were given the vaccine. The Ebola vaccine, known as VSV-EBOV, was developed by Canada's Public Health Agency and licensed to the pharmaceutical firm Merck Sharp & Dohme. World Health Organization's Director-General, Dr. Margaret Chan, praised the Guinean Government, the people living in the Guinea communities and WHO's partners in this project."
"The AP post reported that the announced study involved several thousand people who had been near a new Ebola patient or a close contact of one. The subjects were randomly selected to get the vaccine immediately or in 3 weeks. Researchers began tracking the results ten days after they set up the groups to give time to detect anyone who might have been silently harboring the virus when the study began. After that point, none of the people in the group that had been assigned to get the vaccine right away developed Ebola, versus 16 people in the group eligible to get the vaccine after 21 days."WHO, which sponsored the study, announced that the researchers concluded in July that it would be best to provide every participant in the study with the vaccine, rather administer a placebo. So far, the epidemic has claimed more than 11,000 lives. Many believe that if VSV-EBOV is proven safe and effective, it could be used to vaccinate people in high-risk areas or halt further the progression of the disease.


0 Comments to Ebola Vaccine: Is it over? :

Comments RSS

Add a Comment

Your Name:
Email Address: (Required)
Website:
Comment:
Make your text bigger, bold, italic and more with HTML tags. We'll show you how.
Post Comment